Mice lacking the CB1-, CB2-receptor or both receptors showed aggravation of inflammation in the model of TNBS colitis (30) which suggest that the endocannabinoid system may have tonic inhibitory effects on inflammatory responses in the colon (28). This evidence concerns the gene CNR1 and colitis.